Literature DB >> 8030443

Expression of 92 kD type IV collagenase/gelatinase B in human osteoclasts.

A L Wucherpfennig1, Y P Li, W G Stetler-Stevenson, A E Rosenberg, P Stashenko.   

Abstract

The digestion of type I collagen is an essential step in bone resorption. It is well established that osteoclasts solubilize the mineral phase of bone during the resorptive process, but the mechanism by which they degrade type I collagen, the major proteinaceous component of bone, is controversial. Differential screening of a human osteoclastoma cDNA library was performed to characterize genes specifically expressed in osteoclasts. A large number of cDNA clones obtained by this procedure were found to represent 92 kD type IV collagenase (gelatinase B; MMP-9, EC 3.4.24.35), as well as tartrate-resistant acid phosphatase. In situ hybridization localized mRNA for gelatinase B to multinucleated giant cells in human osteoclastomas. Gelatinase B immunoreactivity was demonstrated in giant cells from eight of eight osteoclastomas, osteoclasts in normal bone, and osteoclasts of Paget's disease by use of a polyclonal antiserum raised against a synthetic gelatinase B peptide. In contrast, no immunoreactivity for 72 kD type IV collagenase (gelatinase A; MMP-2, EC 3.4.24.24), which is the product of a separate gene, was detected in osteoclastomas or normal osteoclasts. We propose that the 92 kD type IV collagenase/gelatinase B plays an important role in the resorption of collagen during bone remodeling.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8030443     DOI: 10.1002/jbmr.5650090415

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  25 in total

1.  Tartrate-resistant purple acid phosphatase is synthesized as a latent proenzyme and activated by cysteine proteinases.

Authors:  J Ljusberg; B Ek-Rylander; G Andersson
Journal:  Biochem J       Date:  1999-10-01       Impact factor: 3.857

2.  Distribution of matrix metalloproteinases and their inhibitor, TIMP-1, in developing human osteophytic bone.

Authors:  S Bord; A Horner; R M Hembry; J J Reynolds; J E Compston
Journal:  J Anat       Date:  1997-07       Impact factor: 2.610

Review 3.  Role of matrix metalloproteinases in dental caries, pulp and periapical inflammation: An overview.

Authors:  Atul Jain; Rachana Bahuguna
Journal:  J Oral Biol Craniofac Res       Date:  2015-07-29

Review 4.  Signaling networks that control the lineage commitment and differentiation of bone cells.

Authors:  Carrie S Soltanoff; Shuying Yang; Wei Chen; Yi-Ping Li
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2009       Impact factor: 1.807

5.  Protease-Activated Receptor 1 Deletion Causes Enhanced Osteoclastogenesis in Response to Inflammatory Signals through a Notch2-Dependent Mechanism.

Authors:  Sandra Jastrzebski; Judith Kalinowski; Sehwan Mun; Bongjin Shin; Naga Suresh Adapala; Christian E Jacome-Galarza; Faryal Mirza; H Leonardo Aguila; Hicham Drissi; Archana Sanjay; Ernesto Canalis; Sun-Kyeong Lee; Joseph A Lorenzo
Journal:  J Immunol       Date:  2019-05-20       Impact factor: 5.422

6.  Amorphous calcium phosphate-mediated binding of matrix metalloproteinase-9 to fibrin is inhibited by pyrophosphate and bisphosphonate.

Authors:  G S Makowski; M L Ramsby
Journal:  Inflammation       Date:  1999-08       Impact factor: 4.092

7.  Macrophage fusion, giant cell formation, and the foreign body response require matrix metalloproteinase 9.

Authors:  Susan MacLauchlan; Eleni A Skokos; Norman Meznarich; Dana H Zhu; Sana Raoof; J Michael Shipley; Robert M Senior; Paul Bornstein; Themis R Kyriakides
Journal:  J Leukoc Biol       Date:  2009-01-13       Impact factor: 4.962

8.  Binding of matrix metalloproteinase 9 to fibrin is mediated by amorphous calcium-phosphate.

Authors:  G S Makowski; M L Ramsby
Journal:  Inflammation       Date:  1998-12       Impact factor: 4.092

9.  Increased matrix metalloproteinases as possible cause of osseoarticular tissue destruction in long-term haemodialysis and beta 2-microglobulin amyloidosis.

Authors:  K Ohashi; R Kawai; M Hara; Y Okada; S Tachibana; Y Ogura
Journal:  Virchows Arch       Date:  1996-04       Impact factor: 4.064

10.  Exposure to pro-inflammatory cytokines upregulates MMP-9 synthesis by mesenchymal stem cells-derived osteoprogenitors.

Authors:  D Ben David; A Z Reznick; S Srouji; E Livne
Journal:  Histochem Cell Biol       Date:  2008-02-15       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.